Health Condition 1: H530- Amblyopia ex anopsia
Conditions
Interventions
Intervention1: Orthoptek Magnocellular stimulator therapy: The patient will sit at a 1 meter distance from the screen and do exercise of following red and green lights , that flashes at an interval of
Sponsors
ALL INDIA INSTITUTE OF MEDICAL SCIENCES
Eligibility
Inclusion criteria
Inclusion criteria: All patients of refractive and strabismic amblyopia visiting our OPD with clear cornea, strabismus, no lenticular opacities, no retinal or optic nerve pathologies, no mechanical lid cause leading to amblyopia. After proper screening and consent patients of refractive and strabismic amblyopia will be randomized on 4- Block basis with, Mild Amblyopia ââ?¬â?? 30-40%, Moderate Amblyopia 30-40% and Severe Amblyopia ââ?¬â?? 20%. After randomization in the Orthoptek group ââ?¬â?? The patient will sit at a 1 meter distance from the screen and do exercise of following red and green lights , that flashes at an interval of 150msec, from the Amblyopic eye for 20 mins, both eyes open 5-7 mins and 5 mins from the normal eye. After a break / rest of 1 hour patient will asked to count flashing lights for 200-300 times. Patient will do all these activities under supervision of an Optometrist / Resident. So, in 1hour -1 therapy will be over. The Orthoptek therapy will be given on alternate days for the first 2 Weeks ââ?¬â?? 6 Sittings in first 15 days followed by once biweekly for 4 sittings and once monthly therapy for 2 sittings if needed for maintenance. In the conventional Occlusion group ââ?¬â?? Occlusion will be given for 4-6 hours every 5 days per week for 3 months preferably when they are at home and on leave from school, college and office. The non-improving patients at last follow ââ?¬â?? up of 6 months will be managed with other modalities of Amblyopia management.
Exclusion criteria
Exclusion criteria: Patients with any pathological ocular disorders and epilepsy will not be considered
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To check if any improvement in the best corrected visual acuity, stereopsis and contrast sensitivity.Timepoint: 18months | — |
Secondary
| Measure | Time frame |
|---|---|
| to look for any recurrence and if improvement in the visual acuity, stereopsis and contrast sensitivity following treatment is maintained or not in the subsequent followup.Timepoint: 1 month and 6 months following treatment. | — |
Countries
India
Contacts
Public ContactDr ARVIND KUMAR MORYA
All India Institute of Medical Sciences
Outcome results
None listed